Subsequent malignant neoplasms (SMNs) in childhood cancer survivors cause substantial
morbidity and mortality. This review summarizes recent literature on SMN epidemiology, risk …

Childhood cancer survivors often experience complications related to cancer and its
treatment that may adversely affect quality of life and increase the risk of premature death …

The development of curative therapy for most pediatric malignancies has produced a
growing population of childhood cancer survivors who are at increased risk for a variety of …

The population of adult survivors of childhood cancer continues to grow as survival rates
improve. Although it is well established that these survivors experience various …

Cancer and its treatment predispose childhood cancer survivors to chronic or late occurring
health problems that may not become clinically significant until many years after therapy …

PURPOSE Therapeutic radiation in childhood cancer has decreased over time with a
concomitant increase in chemotherapy. Limited data exist on chemotherapy-associated …

Purpose Childhood cancer survivors are at risk for long-term morbidity and early mortality.
Since most adult and some adolescent survivors of childhood cancer will receive their long …

The successful treatment of pediatric malignancy by multimodality therapy has improved the
outcome for children with cancer. It has been estimated that 0.1% of individuals 20 years of …

Background: Because survival rates among childhood cancer patients are increasing,
assessing the risk of second and subsequent malignant neoplasms (SMNs) is ever more …

Background Childhood cancer survivors are at risk for treatment‐related adverse health
outcomes, known as late effects. Through matched and longitudinal cohorts, we assessed …